Global recognition for San’s cancer services


Sydney Adventist Hospital has received international recognition for the excellence of its cancer services, adding to its high feedback ratings from patients in New South Wales.

The not-for-profit private facility, known as the San, was listed in Newsweek’s 'World’s Best Specialised Hospitals 2022' report in the area of oncology. 

It featured among the planet's top 250 hospitals in the category following research conducted by Statista in partnership with the news organisation. 

Data was gathered from recommendations by over 40,000 medical experts from 25 countries who were invited to take part in an online survey from June-August 2021.

The San Integrated Cancer Centre is at the heart of the hospital's oncology services, and regularly rates highly in the state's Bureau of Health Information patient survey.

“Over many years, we have developed a high-volume cancer service at the San that incorporates the use of advanced technology with an extremely empathetic approach that treats each patient with unique, individualised care,” said Associate Professor Gavin Marx, the centre's Clinical Director.

The San cancer centre provides state-of-the-art imaging, a full range of high-quality surgical and reconstructive services, comprehensive medical oncology services, expert onsite cancer genetics and extensive cancer support.

Associate Professor Gavin Marx, Clinical Director of the San Integrated Cancer Centre

It is co-located with an Icon Cancer Centre, which supplies the latest in advanced radiation therapy technology and techniques for all cancer types.

"We offer a rapid-access model including the best available diagnostic assessment and senior specialist consultation,” A/Prof Marx added. 

“It's clear that our highly-skilled team, along with constant innovation, has led to excellent patient outcomes and our impressive reputation both in Australia and internationally.”

The San centre’s Clinical Trials Unit also participates in international trials in breast, colorectal, prostate, melanoma and other cancers to give patients the best chances of successful outcomes.

San CEO Brett Goods said he was proud the cancer teams – which also include patient navigators who help people through their treatment journey – had been internationally recognised.

"The Newsweek ranking builds on the San being noted as an oncology leader in local rankings," Mr Goods said. 

"In 2020, for the third consecutive year, the San Integrated Cancer Centre achieved some of the highest ratings in the Bureau of Health Information patient survey, conducted in partnership with the Cancer Institute of NSW."

Read more: San cancer centre tops patient survey

Read more: AI machine personalises cancer therapy


Comments are closed.